FFCP PHASE1:Hg19::chr1:203651149..203651167,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=not | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|coexpression_cluster_id=C3924 | |||
|description=CAGE_peak_at_chr1:203651149..203651167,+ | |||
|id=chr1:203651149..203651167,+ | |||
|ontology_enrichment_celltype=CL:0000764!3.30e-16!2;CL:0000765!3.30e-16!2;CL:0000050!3.30e-16!2;CL:0000038!3.30e-16!2;CL:0000558!3.30e-16!2;CL:0000547!3.30e-16!2;CL:0000549!3.30e-16!2;CL:0000550!3.30e-16!2;CL:0000552!3.30e-16!2 | |||
|ontology_enrichment_celltype_v019=CL:0000764;3.92e-32;2!CL:0000558;3.92e-32;2!CL:0000047;8.41e-09;2 | |||
|ontology_enrichment_celltype_v019_2=CL:0000764,3.35e-32,2;CL:0000765,3.35e-32,2;CL:0000050,3.35e-32,2;CL:0000038,3.35e-32,2;CL:0000558,3.35e-32,2;CL:0000547,3.35e-32,2;CL:0000549,3.35e-32,2;CL:0000550,3.35e-32,2;CL:0000552,3.35e-32,2;CL:0000763,3.43e-13,108;CL:0000049,3.43e-13,108;CL:0002032,1.50e-08,161;CL:0000837,1.50e-08,161;CL:0000037,3.74e-08,168;CL:0000988,1.09e-07,177 | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:1036!5.20e-23!8;DOID:8692!6.66e-18!31;DOID:1240!6.11e-14!39;DOID:2531!2.52e-10!51;DOID:0060083!2.52e-10!51;DOID:8552!7.56e-09!1 | |||
|ontology_enrichment_disease_v019=DOID:1036;1.88e-47;8!DOID:8692;3.33e-31;31!DOID:1240;3.30e-21;39!DOID:8552;8.86e-17;1!DOID:2531;3.52e-14;51!DOID:0060083;3.52e-14;51 | |||
|ontology_enrichment_disease_v019_2=DOID:1036,1.88e-47,8;DOID:8692,6.96e-31,31;DOID:1240,1.88e-24,39;DOID:2531,1.42e-18,51;DOID:0060083,1.42e-18,51;DOID:8552,8.86e-17,1 | |||
|ontology_enrichment_uberon=UBERON:0004177!1.25e-09!7;UBERON:0002146!2.29e-08!1;UBERON:0005623!2.29e-08!1;UBERON:0002370!6.47e-08!4;UBERON:0005058!6.47e-08!4;UBERON:0009113!6.47e-08!4;UBERON:0003295!6.47e-08!4;UBERON:0005562!6.47e-08!4;UBERON:0000974!7.18e-07!10 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.47752944117631,0,0.393010762749165,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.113309342697566,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.30139853857622,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.2252308717992,16.9933043166185,0,0,0,0.103041011647722,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.0013618632026,0.811367035427949,0,5.63948020351398,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.97543082260845,4.51191321234361,6.66612616680314,4.02771808742022,14.4212836870381,7.78789237003856,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.229160424011684,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.104909176269996,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.32506888912221,0,0,0,0,0,0.628817220398664,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.150962843566674,0,0,0,0,0,0,0,0.4226557275834,0,0,0.644578879735772,0,0.178553938605658,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.151557396436479,0,0,0,0.639701945702943,0,0.193766729508018,0.186224142887574,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr1:203651149..203651167,+ | |||
}} |
Revision as of 23:33, 10 January 2014
Short description: | p@chr1:203651149..203651167, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr1:203651149..203651167, + |
Coexpression cluster: | C3924_acute_Reticulocytes_chronic_CD34_Fibroblast_Smooth_cord |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
erythroid lineage cell | 3.35e-32 | 2 |
erythroblast | 3.35e-32 | 2 |
megakaryocyte-erythroid progenitor cell | 3.35e-32 | 2 |
erythroid progenitor cell | 3.35e-32 | 2 |
reticulocyte | 3.35e-32 | 2 |
proerythroblast | 3.35e-32 | 2 |
basophilic erythroblast | 3.35e-32 | 2 |
polychromatophilic erythroblast | 3.35e-32 | 2 |
orthochromatic erythroblast | 3.35e-32 | 2 |
myeloid cell | 3.43e-13 | 108 |
common myeloid progenitor | 3.43e-13 | 108 |
hematopoietic oligopotent progenitor cell | 1.50e-08 | 161 |
hematopoietic multipotent progenitor cell | 1.50e-08 | 161 |
hematopoietic stem cell | 3.74e-08 | 168 |
hematopoietic cell | 1.09e-07 | 177 |
Ontology term | p-value | n |
---|---|---|
chronic leukemia | 1.88e-47 | 8 |
myeloid leukemia | 6.96e-31 | 31 |
leukemia | 1.88e-24 | 39 |
hematologic cancer | 1.42e-18 | 51 |
immune system cancer | 1.42e-18 | 51 |
chronic myeloid leukemia | 8.86e-17 | 1 |